BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 52.10
-0.20 (-0.38%)
At close: Feb 11, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 3.65 billion as of February 13, 2026. Its market cap has increased by 13.26% in one year.
Market Cap
3.65B
Enterprise Value
2.51B
Revenue
105.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.10
Market Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 3.65B, a decrease of -4.40%. That is a compound annual growth rate of -3.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.65B | -7.30% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tait Marketing & Distribution | 3.71B |
| Genovate Biotechnology | 3.71B |
| Chip Hope | 3.68B |
| Zen Voce | 3.68B |
| Richmond International Travel & Tours Co.,Ltd | 3.68B |
| Celxpert Energy | 3.67B |
| CastleNet Technology | 3.65B |
| Kura Sushi Asia | 3.65B |